Cécile L Berends

4PUBLICATIONS
5CO-AUTHORS
Economic models and forecastingBasic pharmacologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 10, 2022
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.

Manon L M Prins, Johan L van der Plas, Maurits F J M Vissers

|May 28, 2021
First-in-human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR-324, a dual enkephalinase inhibitor for pain management.

Laurence M Moss, Cecile L Berends, Emilie M J van Brummelen

|May 01, 2021
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.

Michelle L Mellion, Lucienne Ronco, Cecile L Berends

|Mar 25, 2021
A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.

Cécile L Berends, Lisa Pagan, Michiel J van Esdonk

Pageof 1

Frequent Collaborators

1 joint publications

Michiel J van Esdonk

1 joint publications

Laurence M Moss

1 joint publications

Emilie M J van Brummelen

1 joint publications

Geert Jan Groeneveld